Collectively, these mechanisms allow circ0001955 to restore the carcinogenic activity of ARF6, SPATS2, TRAF6, and MAPK11 in chronically HCV-infected hepatocytes, promoting the initiation and progression of hepatocellular carcinoma. The gene discussed is SPATS2; the disease is hepatocellular carcinoma.